How much did Moderna bribe UK Health Regulators and politicians to sign a billion pound contract for a “universal mRNA flu vaccine”? Zero? 20 million pounds? 50 million pounds?

Children’s Health Defence has picked up a YouTube video made by Dr John Campbell about a contract signed by the UK Government with Moderna.

Here is a link to the video: mRNA influenza vaccine - YouTube

And a link to the CHD article with a lot more narrative: UK Commits £1 Billion for Moderna’s mRNA Universal Flu Vaccine Despite Lack of Scientifically Sound Data • Children's Health Defense (childrenshealthdefense.org)

Let’s leave aside that there is no true placebo – the mRNA flu “vaccine” will be tested against a quadrivalent flu shot, not against healthy people that have neither received the mRNA or the quadrivalent shots.

The wilful misconduct of the UK government and health authorities is the signing of a contract for an injection that has not even completed Phase 1 of clinical trials.

Would anyone be in the least surprised if those approving this billion pound contract ended up as highly paid executives of Moderna at some point in time in the future? Or that substantial (million pound and up) “backhanders” or “payments in kind” were paid? Makes you wonder just how competitive the “bidding process” was for an experimental treatment – were Novavax or Pfizer invited to receive a billion pounds to set up a production facility to produce mRNA flu injections? How about using viral vector instead? AstraZeneca, JnJ or Janssen might have learned from their mistakes.

All this against the backdrop of the PROVEN FAILURE OF mRNA TECHNOLOGY evidenced from 6 months of clinical trials, through the last 30 months for failure to prevent infection, transmission, hospitalization or death of C19 and known to cause significant harms and deaths – even more than Pfizer/BioNTech’s shots.

To say this is a “parody of research” is a massive understatement. I wonder how quickly Phase 2

The lipid nano-particle delivery mechanism is know to be toxic.

Here’s Dr Campbell’s bullet points for his video:

https://www.niaid.nih.gov/news-events...

 https://clinicaltrials.gov/ct2/show/N...

“Clinical trial, experimental universal influenza vaccine

National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC), (part of National Institutes of Health)

Enrolling volunteers, Duke University, Durham, North Carolina

Phase 1 trial H1ssF-3928 mRNA-LNP, for safety and ability to induce an immune response. N = up to 50 healthy volunteers, (18 through 49) Three groups of 10 participants each 10, 25 and 50 micrograms After evaluation of the data to determine an optimum dosage, an additional 10 to receive the optimum dosage Study include a group, receive a current quadrivalent.

Comparison between “immunogenicity and safety” Follow-up appointments for up to one year

Annual seasonal flu vaccines - valuable tools in controlling the spread and severity of influenza. Do not provide immunity against every flu strain. Each year is based on prediction. Vaccine manufacturers then need time (dominant strains of the virus can change).

An effective universal flu vaccine - Acting NIAID Director Hugh Auchincloss - Protecting its recipients against a wide variety of strains, ideally providing durable long-term immunity. “A universal influenza vaccine would be a major public health achievement and could eliminate the need for both annual development of seasonal influenza vaccines, as well as the need for patients to get a flu shot each year” Defence against the spread of a future flu pandemic.

Both vaccines use a specific portion of a flu protein, Hemagglutinin (HA) stern (not head) flu protein

UK cements 10-year-partnership with Moderna in major boost for vaccines and research https://www.gov.uk/government/news/uk... to produce up to 250 million vaccines per year https://www.theguardian.com/business/...

£1bn deal with the UK government UK government has committed to buying Moderna’s vaccines for the next decade. Harwell, Oxfordshire https://www.bbc.co.uk/news/uk-england... Innovation and Technology Centre built by the 2025

Moderna provide the UK public with access to mRNA vaccines for a wide range of respiratory diseases

Questions

Control of antigen dose? How long antigen will be produced for? Degree of systemic distribution? Degree of systemic inflammation?”

As a reminder here are the four stages of a clinical trial taken from here:

Phases of Clinical Trials | Cancer.Net

Phase I clinical trials

Doctors do a phase I clinical trial to learn if a new drug, treatment, or treatment combination is safe for people. They may have already tested it in laboratory animals.

In a phase I clinical trial, doctors collect information on:

The dose or treatment

When you take it, and how often

Any side effects or problems

How the treatment affects you, such as how it affects the cancer or side effects

In a phase I clinical trial, you could be one of the first people to get the new drug or treatment.

Phase I clinical trials each last several months to a year. They usually have 10 to 30 volunteers.

Phase II clinical trials

A phase II clinical trial tells doctors more about how safe the treatment is and how well it works. Doctors also test whether a new treatment works for a specific cancer. They might measure the tumor, take blood samples, or check how well you can do certain activities. Or you might keep a log of your daily activities and symptoms. These are all ways to learn how well the treatment works.

A Phase II clinical trial lasts about 2 years. Volunteers sometimes receive different treatments. For example, a phase II trial could have 2 groups.

Group 1 – People who receive the usual treatment for the condition. This is also called the standard treatment. It is the best treatment known.

Group 2 – People who receive the usual treatment plus the new treatment doctors are studying.

Or a phase II clinical trial could have 3 groups. Volunteers in each group get a different dose of the treatment doctors are studying .If the phase II clinical trial shows the treatment works and is as safe as the regular treatment, doctors can do a phase III trial.

Phase III clinical trials

A phase III clinical trial tests a treatment that worked well for volunteers in a phase II clinical trial. Doctors use phase III to compare the new treatment with the standard treatment. They want to know if the new treatment is better, has fewer side effects, or both. So they put volunteers in different groups. The volunteers in each group get a different treatment.

Phase III clinical trials can take many years. They may have several thousand volunteers. These must include men, women, and people of different ages and ethnic groups, if possible. This helps doctors learn how the treatment works in different people.

If a phase III clinical trial shows the treatment works well, doctors might begin using it with people outside the clinical trial. For example, if they learn that a certain amount of exercise lowers your cancer risk, they publish a report. This shares the information with other doctors. If the researchers or sponsor learn a new medicine is safe and effective, they can ask the government to approve it for people to use. In the United States, they ask the Food and Drug Administration (FDA). The FDA looks at the results of the clinical trial's phases. They approve the treatment if the results meet their standards.

Phase IV clinical trials

Doctors can prescribe a drug for their patients after the FDA approves it. But the FDA may require the sponsor to keep studying that approved treatment. In these clinical trials, doctors may check if the treatment benefits people as much as it did earlier. They also look for more possible side effects. These clinical trials are called phase IV clinical trials.

In a Phase IV clinical trial, doctors might study the drug or treatment in different doses, or with other drugs or treatments. Or they might study how it works if people take it at different times. They might study it in different people than earlier clinical trials did. For example, they might study how well it works for children or older adults. Doctors can also study how well a drug or treatment works over time.

Drug makers may do phase IV clinical trials even if the FDA does not ask them to. They might do this to get FDA approval to use the drug in a new way. For example, they might want to use it for another type of cancer.Phase IV clinical trials can also check the safety of drugs or treatments being used now. They do this to make sure drug makers report any new or serious side effects. The FDA may take away a drug's approval if new research shows it is not as safe or effective as earlier testing showed. Doctors cannot prescribe it any longer if this happens.”

Onwards!

Please upgrade to paid, or donate a coffee (I drink a lot of coffee) - “God Bless You!” if you can’t or don’t want to contribute. Coffee donations here: https://ko-fi.com/peterhalligan  - Buying just one Ko-Fi a week  for $3 is 50 bucks more than an annual $100 subscription!